Literature DB >> 1174040

[Phalloidine antagonists. 1. Effects of silybine derivatives on isolated perfused rat liver].

V M Frimmer, R Kroker.   

Abstract

The protective effect of two silybin derivatives against phalloidin was tested in isolated rat livers, perfused with an erythrocyte free medium. Both liver swelling and potassium loss were examined for the evaluation of antagonism. Liver swelling and potassium loss were markedly decreased when silybin hemisuccinate was added to the perfusion medium before the application of phalloidin. In contrast, the protective effect of this compound was minimal after the mushroom toxin was partially absorbed by the liver. The protective efficiency of a dimer derivative (disilybin) was much greater than that of the monomer product. The binding of both derivatives in the liver cannot be very strong because the protective effect mainly could be washed out by a single change of the perfusion medium. Spectroscopical studies on isolated hepatocytes indicate that silybin inhibits the interaction of phalloidin with the cell surface.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1174040

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Antagonistic effects against single lethal doses of Amanita phalloides.

Authors:  G L Floersheim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

2.  Toxicity of a highly purified leucocidin from Pseudomonas aeruginosa in perfused rat livers.

Authors:  M Frimmer; W Scharmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  The role of bile acids in phalloidin poisoning.

Authors:  M Frimmer; E Petzinger; U Rufeger; L B Veil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

4.  Anti-phalloidine and anti-alpha-amanitine action of silybin in comparison with compounds similar to structural parts of silybin.

Authors:  W Trost; G Halbach
Journal:  Experientia       Date:  1978-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.